These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 557448)

  • 1. Comparative cytogenetic and histologic studies on early malignant transformation in mesothelial tumors of the ovary.
    Knoerr-Gaertner H; Schuhmann R; Kraus H; Uebele-Kallhardt B
    Hum Genet; 1977 Mar; 35(3):281-97. PubMed ID: 557448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
    Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
    J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative serous tumors of the ovary. Histologic features and prognosis.
    Katzenstein AL; Mazur MT; Morgan TE; Kao MS
    Am J Surg Pathol; 1978 Dec; 2(4):339-55. PubMed ID: 736209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma.
    Hill SM; Rodgers CS; Hultén MA; Wilson AP
    Cancer Genet Cytogenet; 1984 Aug; 12(4):321-7. PubMed ID: 6744227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of papillary tubal hyperplasia (PTH), salpingoliths and transition from adenoma to borderline ovarian tumors (BOT): A systematic analysis of 74 BOT with different histologic types.
    Horn LC; Angermann K; Hentschel B; Einenkel J; Höhn AK
    Pathol Res Pract; 2017 Apr; 213(4):305-309. PubMed ID: 28238382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors.
    Pejovic T; Heim S; Mandahl N; Elmfors B; Flodérus UM; Furgyik S; Helm G; Willén H; Mitelman F
    Genes Chromosomes Cancer; 1990 May; 2(1):48-52. PubMed ID: 2177641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal aberrations in an ovarian cystadenoma.
    Benedict WF; Rosen WC; Brown CD; Porter IH
    Lancet; 1969 Sep; 2(7621):640. PubMed ID: 4185609
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative cytogenetic studies of benign, borderline, and malignant epithelial ovarian tumors.
    Izutsu T; Kudo T; Shoji T; Nishiya I
    J Obstet Gynaecol Res; 1996 Dec; 22(6):541-9. PubMed ID: 9037943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
    Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
    Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosome abnormalities in an ovarian cancer].
    Berger R; Lacour J
    Pathol Biol (Paris); 1974 Sep; 22(7):603-6. PubMed ID: 4612464
    [No Abstract]   [Full Text] [Related]  

  • 11. Centromere spreading and centromeric aberrations in ovarian tumors.
    Zhu D; Ma MS; Zhao RZ; Li MY
    Cancer Genet Cytogenet; 1995 Mar; 80(1):63-5. PubMed ID: 7697635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic observations on two ovarian carcinomas with double minutes, one with a 6q- marker chromosome.
    Bullerdiek J; Bartnitzke S; Kahrs E; Schloot W
    Cytobios; 1985; 42(165):15-24. PubMed ID: 3858061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borderline malignant serous tumors of the ovary maintained on extracellular matrix: evidence for clonal evolution and invasive potential.
    Crickard K; Marinello MJ; Crickard U; Satchidanand SK; Yoonessi M; Caglar H
    Cancer Genet Cytogenet; 1986 Oct; 23(2):135-43. PubMed ID: 3756833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
    Zhong CQ
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A serous cystadenoma of the ovary of borderline malignancy with a fifteen-year history. A case report].
    Nagata O; Aramaki S; Iino H; Ishikawa S; Yoshida H; Azekami M; Yamaguchi Y; Iwasa T; Matsukuma K; Iwata Y
    Gan No Rinsho; 1990 Apr; 36(5):669-73. PubMed ID: 2325270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal analysis in malignant ovarian tumors.
    Sonwalker AA; Grover S
    Am J Obstet Gynecol; 1974 Apr; 118(7):961-5. PubMed ID: 4361960
    [No Abstract]   [Full Text] [Related]  

  • 17. A benign serous ovarian cystadenoma studied by chromosome and quantitative DNA analysis.
    Wager J; Granberg I; Vass L; Auer G
    Acta Cytol; 1977; 21(6):774-6. PubMed ID: 274883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras oncogene product p21 expression and prognosis of human ovarian tumors.
    Yaginuma Y; Yamashita K; Kuzumaki N; Fujita M; Shimizu T
    Gynecol Oncol; 1992 Jul; 46(1):45-50. PubMed ID: 1634140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chromosome study of three ovarian tumors.
    Jenkyn DJ; McCartney AJ
    Cancer Genet Cytogenet; 1987 Jun; 26(2):327-37. PubMed ID: 3471312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
    Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.